Hexagon Capital Partners LLC Ironwood Pharmaceuticals Inc Transaction History

Hexagon Capital Partners LLC

  • $448 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023
SELL
$8.25 - $11.35 $1,641 - $2,258
-199 Closed
0 $0
Q2 2023

Jul 24, 2023
BUY
$10.1 - $11.6 $595 - $684
59 Added 42.14%
199 $2,000
Q1 2023

Apr 24, 2023
BUY
$10.37 - $12.56 $1,078 - $1,306
104 Added 288.89%
140 $1,000
Q3 2022

Oct 17, 2022
BUY
$10.14 - $12.38 $365 - $445
36 New
36 $0

Others Institutions Holding IRWD

# of Institutions
296
Shares Held
170M
Call Options Held
27.1M
Put Options Held
2.28M
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $953M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email